Literature DB >> 3999223

Functional properties of natural killer cells in carcinoma of the prostate.

M Wirth, B J Schmitz-Dräger, R Ackermann.   

Abstract

Functional properties of natural killer cells were analyzed in a 51chromium-release assay by modulating their activity with human beta-interferon using 1) peripheral mononuclear cells of 16 patients with carcinoma of the prostate and 7 healthy male donors, and 2) mononuclear cells from the periprostatic lymph nodes of 6 patients with stage pT2N0M0 prostatic cancer and 5 without malignancy. Cell lines EB 33, PC 3, DU 145 and CaKi 1 were used as target cells. Spontaneous cell-mediated cytotoxicity of peripheral mononuclear cells was depressed in patients with advanced prostatic cancer; however, the natural killer cells responded as those of the healthy controls to beta-interferon. The beta-interferon effect was time and dose dependent. In mononuclear periprostatic lymph node cells virtually no spontaneous cell-mediated cytotoxicity was detected. The reactivity of mononuclear periprostatic lymph node cells from patients with prostatic cancer was significantly less improved by beta-interferon stimulation than the mononuclear periprostatic lymph node cells of healthy subjects. The stimulation of mononuclear periprostatic lymph node cells by beta-interferon was reduced significantly compared to simultaneously tested autologous peripheral mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3999223     DOI: 10.1016/s0022-5347(17)49339-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Lymphocyte subsets in urologic cancer patients.

Authors:  M Shaw; P Ray; M Rubenstein; P Guinan
Journal:  Urol Res       Date:  1987

2.  Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.

Authors:  J W Grups; T Stock; H G Frohmüller
Journal:  Urol Res       Date:  1988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.